Kunin Audrey (CIK 0001738781)

Latest company ownership

NBY - NovaBay Pharmaceuticals, Inc.

Role: Chief Product Officer

Shares held

1

Last filed at

Dec 5, 2022

Confidence Score

50.0

2025Q4

Confidence Score History

2021Q4 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Dec 6, 2022	Dec 7, 2022	NovaBay Pharmaceuticals, Inc.	Chief Product Officer	Sell	27.5	-1	-100.00%	✗	$1.8
Nov 21, 2022	Dec 5, 2022	NovaBay Pharmaceuticals, Inc.	Chief Product Officer	Sell	26.3	-5,960	-99.98%	✗	$12.5K
Nov 21, 2022	Nov 23, 2022	NovaBay Pharmaceuticals, Inc.	Chief Product Officer	Sell	26.3	-5,960	-100.00%	✗	$12.5K
Sep 14, 2022	Sep 16, 2022	NovaBay Pharmaceuticals, Inc.	Chief Product Officer	Sell	26.3	-291,368	-58.27%	✗	$46.1K
Dec 3, 2021	Dec 7, 2021	NovaBay Pharmaceuticals, Inc.	Chief Product Officer	Buy	91.3	+101,650	25.52%	✗	$47K
Dec 2, 2021	Dec 6, 2021	NovaBay Pharmaceuticals, Inc.	Chief Product Officer	Buy	95.0	+262,369	192.95%	✗	$124.9K
Dec 1, 2021	Dec 3, 2021	NovaBay Pharmaceuticals, Inc.	Chief Product Officer	Buy	90.0	+14,848	12.26%	✗	$7.3K
Nov 30, 2021	Dec 2, 2021	NovaBay Pharmaceuticals, Inc.	Chief Product Officer	Buy	91.3	+30,000	32.92%	✗	$13.8K
Nov 22, 2021	Nov 24, 2021	NovaBay Pharmaceuticals, Inc.	Chief Product Officer	Buy	91.3	+91,133	100.00%	✗	$41.9K